News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Spreeha Choudhury, JD, PharmD

Advertisement

Articles by Spreeha Choudhury, JD, PharmD

Choudhury and Arville

Navigating Pharmacy Models and Regulatory Pitfalls When Launching Direct-To-Consumer Programs

ByAlan Arville, JD,Spreeha Choudhury, JD, PharmD
October 10th 2025

Launching DTC models requires navigating regulatory and licensing rules.

Spreeha Choudhury Richard Choudhury

Don’t Fall for the Call of Placebo-Controlled Vaccine Trials

BySpreeha Choudhury, JD, PharmD,Richard Hughes IV
June 25th 2025

The idea of denying people proven medicines in the name of research has a dark legacy in this country.

Advertisement

Latest Updated Articles

  • Choudhury and Arville
    Navigating Pharmacy Models and Regulatory Pitfalls When Launching Direct-To-Consumer Programs

    October 10th 2025



Advertisement
Advertisement

Trending on PharmExec

1

Medical Supply Chains at Risk Over Escalating Conflicts in Iran: Report

2

Novavax Stock Increases as Shah Capital Plans to Vote Against Board Nominees

3

What Unexpected Costs do GLP-1 Patients Face?

4

Q&A: Supply Chain Fallout From Iran War, Tariff Uncertainty

5

Wegovy HD Now Available in the U.S.

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us